Tuesday, 12 June 2018

Orexin/hypocretic receptor signalling and cancer.

›
Let's consider Orexin/hypocretin receptor signalling and how we may exploit this system for brain cancer management. As we can see i...
Sunday, 13 May 2018

Reaction to Tessa Jowell's death, thoughts on repurposed drugs and deuterium. Update on Sativex.

›
Links relating to subjects mentioned: Deuterium content of water increases depression susceptibility https://www.sciencedirect.com/sci...
1 comment:
Thursday, 8 March 2018

L-Carnitine, ketolytic enzymes and therapeutic ketogenic diets for cancer management.

›
L-Carnitine plays an absolutely vital role in the metabolism of fatty acids. Mo Farah is recently, somewhat controversially been pruported...
12 comments:
Thursday, 1 March 2018

Telomere biology and cancer

›
When I was first diagnosed I asked my oncologist about my prognosis and was told... 'well the good news is that you are still quite you...
5 comments:
Sunday, 4 February 2018

World Cancer Day

›
I am in my 5th year since being diagnosed with incurable brain cancer. I should be happy right? Well, sometimes yes, sometimes no. Its comp...
7 comments:
Friday, 12 January 2018

Blue light blocking glasses and cancer, epilepsy

›
These are the best blue light blocking glasses I have had and they don't look dorky. If you understand about the negative effects of art...
6 comments:
Saturday, 23 December 2017

Erenumab and other CGRP receptor antagonists- potential for action against brain tumours?

›
At the moment I'm keeping an eye on trial results and emerging research of this relatively new medication (Erenumab) for episodic migrai...
4 comments: